CDC criticized for lack of leadership in curbing hospital infections

Article

The Government Accountability Office urged Health & Human Services to prioritize practice recommendations from the Centers for Disease Control & Prevention in order to prevent hospital infections.

At a hearing before the U.S. House of Representatives Committee on Government Oversight and Reform this week, numerous parties came forward to make the point that there are still too many healthcare-associated infections in this country. The Government Accountability Office came out with a

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!
Recent Videos
Related Content
Iowa Governor Signs Bill Limiting PBM Practices

Iowa Governor Signs Bill Limiting PBM Practices

Brian Nowosielski
June 12th 2025
Article

SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.

Pharmacy Law Lowdown: PBM Audit Trends, Enforcement Actions

Pharmacy Law Lowdown: PBM Audit Trends, Enforcement Actions

Killian Meara;Dae Lee, PharmD, Esq, CPBS ;Lucas Morgan, Esq
May 14th 2025
Podcast

Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.

FDA Approves Fitusiran as Prophylaxis of Bleeding Episodes Due to Hemophilia A or B

FDA Approves Fitusiran as Prophylaxis of Bleeding Episodes Due to Hemophilia A or B

Ashley Gallagher
March 28th 2025
Article

Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.

The Current, Future Roles of AI within the Pharmacy Profession

The Current, Future Roles of AI within the Pharmacy Profession

Brian Nowosielski;Scott Nelson, PharmD, MS, FAMIA, ACHIP
February 27th 2025
Podcast

As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.

Bipartisan Bill Aims to Combat PBMs’ Medicaid Spread-Pricing

Bipartisan Bill Aims to Combat PBMs’ Medicaid Spread-Pricing

Brian Nowosielski
March 13th 2025
Article

US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.

Q&A: Challenges Health Systems May Face When Integrating Biosimilars

Q&A: Challenges Health Systems May Face When Integrating Biosimilars

Killian Meara;Chelsee Jensen, PharmD, BCPS
March 11th 2025
Article

A conversation with Chelsee Jensen, PharmD, BCPS, director of formulary management at the Mayo Clinic.

© 2025 MJH Life Sciences

All rights reserved.